|
Diabetes, Vol 48, Issue 10 2059-2065, Copyright © 1999 by American Diabetes Association
Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes
J Ren, LJ Dominguez, JR Sowers and AJ Davidoff
University of North Dakota School of Medicine, Grand Forks, North Dakota, USA. jren@medicine.nodak.edu
We have recently demonstrated that adult rat ventricular myocytes
maintained in a high glucose (HG) culture medium exhibit abnormalities in
excitation-contraction coupling similar to myocytes from diabetic rats.
Metformin, an insulin-sensitizing biguanide, enhances peripheral insulin
action and lowers blood pressure in hyperinsulinemic animals, but its
direct impact on cardiac function is not fully understood. To examine the
role of metformin on HG-induced cardiac dysfunction at the cellular level,
normal adult ventricular myocytes were cultured for 1 day in a serum-free
insulin-containing medium with either normal glucose (5.5 mmol/l glucose)
or HG (25.5 mmol/l glucose) in the presence or absence of metformin or the
sulfonylurea glyburide. Mechanical properties were evaluated using a
high-speed video-edge detection system, and intracellular Ca2+ transients
were recorded in fura-2-loaded myocytes. As previously reported, culturing
myocytes in HG depresses peak shortening, prolongs time to 90%
relengthening, and slows Ca2+ transient decay. Culturing cells with
metformin (50 micromol/l) prevented the HG-induced abnormalities in
relaxation without ameliorating depressed peak-shortening amplitudes.
Incubation of the cells with metformin also prevented slower intracellular
Ca2+ clearing induced by HG. However, the HG-induced relaxation defects
were not improved by glyburide (50-300 micromol/l). Interestingly,
metformin also improved HG-induced relaxation abnormalities in the absence
of insulin, whereas it failed to protect against HG in the presence of the
tyrosine kinase inhibitor genistein (50 micromol/l). These data demonstrate
that, unlike glyburide, metformin provides cardioprotection against
HG-induced abnormalities in myocyte relaxation, perhaps through tyrosine
kinase-dependent changes in intracellular Ca2+ handling, independent of its
insulin sensitizing action.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S.-Y. Li, C. X Fang, N. S Aberle II, B. H Ren, A. F Ceylan-Isik, and J. Ren
Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function
J. Endocrinol.,
September 1, 2005;
186(3):
491 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Clement, S. S. Braithwaite, M. F. Magee, A. Ahmann, E. P. Smith, R. G. Schafer, and I. B. Hirsch
Management of Diabetes and Hyperglycemia in Hospitals
Diabetes Care,
February 1, 2004;
27(2):
553 - 591.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Privratsky, L. E. Wold, J. R. Sowers, M. T. Quinn, and J. Ren
AT1 Blockade Prevents Glucose-Induced Cardiac Dysfunction in Ventricular Myocytes: Role of the AT1 Receptor and NADPH Oxidase
Hypertension,
August 1, 2003;
42(2):
206 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ye, N. S. Metreveli, J. Ren, and P. N. Epstein
Metallothionein Prevents Diabetes-Induced Deficits in Cardiomyocytes by Inhibiting Reactive Oxygen Species Production
Diabetes,
March 1, 2003;
52(3):
777 - 783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Duan, H.-Y. Zhang, S. D. Adkins, B. H. Ren, F. L. Norby, X. Zhang, J. N. Benoit, P. N. Epstein, and J. Ren
Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA
Am J Physiol Endocrinol Metab,
February 1, 2003;
284(2):
E366 - E376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. L. Norby, L. E. Wold, J. Duan, K. K. Hintz, and J. Ren
IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes
Am J Physiol Endocrinol Metab,
October 1, 2002;
283(4):
E658 - E666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kirpichnikov, S. I. McFarlane, and J. R. Sowers
Metformin: An Update
Ann Intern Med,
July 2, 2002;
137(1):
25 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Dutta, D. A. Podolin, M. B. Davidson, and A. J. Davidoff
Cardiomyocyte Dysfunction in Sucrose-Fed Rats Is Associated With Insulin Resistance
Diabetes,
May 1, 2001;
50(5):
1186 - 1192.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|